BioSpace News Archive

Policy

GenePOC® Launches its GenePOC® CDiff Test in Canada

GenePOC announces the Health Canada approval and launch of its molecular diagnostic test for the detection of Clostridium difficile in Canada

October 23, 2018
·
2 min read
Business

Siemens Healthineers and Healthy.io Align Expertise to Improve Kidney Disease Compliance with Home Testing

The companies will integrate Siemens Healthineers urinalysis reagents into the Healthy.io’s smartphone-based urinalysis system.

October 23, 2018
·
3 min read
BioCapital

CavoGene LifeSciences Licenses Novel Gene Therapy for CNS Disorders

Agreement with University California San Diego Provides License for Production of SynCav1, an Investigational Novel Gene Therapy for Treatment of Alzheimer’s Disease and Amyotrophic Lateral Sclerosis

October 23, 2018
·
3 min read
Biotech Bay

ClearLight Biotechnologies, LLC (ClearLight) (Formerly: ClearLight Diagnostics, LLC) Announces a Company Name Change and the Introduction of a Pilot Laboratory Service Model Based on the CLARITY Technology

Effective immediately, ClearLight announces a company name change to CLEARLIGHT BIOTECHNOLOGIES, LLC.

October 23, 2018
·
2 min read
Pharm Country

Kibow Biotech to Exhibit Its “Enteric Dialysis®" Technology and Renadyl™ to Delay The Need For Hemo/Peritoneal Dialysis at the Annual ASN 2018 - Kidney Week Conference

Kibow Biotech is proud to announce its 21st year of operations as a pioneer with the use of Pro/Prebiotics in people with failing kidneys. Kibow has been participating and exhibiting at the annual meeting of the American Society of Nephrology being held from Oct 22–28, San Diego, CA.

October 23, 2018
·
6 min read
Lone Star Bio

Former Red Bull UK CEO Announces New Line of CBD Detox Drinks For Liver Health, Designed to Tackle The Causes of Hangovers and Alcohol Addiction

Sober Up® to Add CBD Line of Products in Coming Months

October 23, 2018
·
1 min read
Business

Edwards Comments On German Court Decision

The injunction will only become effective if Boston Scientific enforces it and provides a bond of €10 million.

October 23, 2018
·
2 min read
Drug Development

Enanta Pharmaceuticals Announces Positive Phase 1 Results and Initiation of Phase 2a Clinical Study of EDP-938 for Respiratory Syncytial Virus

Study to evaluate the safety, pharmacokinetics and antiviral activity of multiple doses of orally administered EDP-938 against respiratory syncytial virus infection in a human challenge study.

October 23, 2018
·
6 min read
Business

CANbridge Pharmaceutical Inc. and WuXi Biologics Enter into Strategic Partnership for Rare Disease Therapeutics

CANbridge Plans to Submit First Rare Disease IND in China in 2019

October 23, 2018
·
3 min read
DarioHealth’s Digital Health Blood Glucose Monitoring System Compatible With New iPhone XS and XS Max

Analyst estimates 75-80 Million iPhone Shipments in 2H 2018

October 23, 2018
·
3 min read